AT501955B1 - Mutierte aox1-promotoren - Google Patents
Mutierte aox1-promotoren Download PDFInfo
- Publication number
- AT501955B1 AT501955B1 AT0030405A AT3042005A AT501955B1 AT 501955 B1 AT501955 B1 AT 501955B1 AT 0030405 A AT0030405 A AT 0030405A AT 3042005 A AT3042005 A AT 3042005A AT 501955 B1 AT501955 B1 AT 501955B1
- Authority
- AT
- Austria
- Prior art keywords
- promoter
- nucleotides
- cell
- nucleic acid
- expression
- Prior art date
Links
- 102100036826 Aldehyde oxidase Human genes 0.000 title 1
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 title 1
- 230000027455 binding Effects 0.000 claims abstract description 127
- 108091023040 Transcription factor Proteins 0.000 claims abstract description 114
- 102000040945 Transcription factor Human genes 0.000 claims abstract description 114
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 108
- 239000002773 nucleotide Substances 0.000 claims abstract description 106
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 106
- 230000035772 mutation Effects 0.000 claims abstract description 57
- 101710194180 Alcohol oxidase 1 Proteins 0.000 claims abstract description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 345
- 108090000623 proteins and genes Proteins 0.000 claims description 161
- 230000014509 gene expression Effects 0.000 claims description 157
- 210000004027 cell Anatomy 0.000 claims description 108
- 102000004169 proteins and genes Human genes 0.000 claims description 88
- 150000007523 nucleic acids Chemical class 0.000 claims description 81
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 76
- 239000008103 glucose Substances 0.000 claims description 76
- 238000012217 deletion Methods 0.000 claims description 75
- 230000037430 deletion Effects 0.000 claims description 75
- 102000039446 nucleic acids Human genes 0.000 claims description 63
- 108020004707 nucleic acids Proteins 0.000 claims description 63
- 239000013598 vector Substances 0.000 claims description 60
- 239000012634 fragment Substances 0.000 claims description 46
- 239000002609 medium Substances 0.000 claims description 43
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 35
- 230000012010 growth Effects 0.000 claims description 25
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 24
- 210000005253 yeast cell Anatomy 0.000 claims description 24
- 241000235648 Pichia Species 0.000 claims description 23
- 230000009466 transformation Effects 0.000 claims description 21
- 230000001939 inductive effect Effects 0.000 claims description 20
- 239000003550 marker Substances 0.000 claims description 18
- 108010084455 Zeocin Proteins 0.000 claims description 16
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 claims description 16
- 230000003115 biocidal effect Effects 0.000 claims description 15
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 12
- 239000000600 sorbitol Substances 0.000 claims description 12
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 11
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 11
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 11
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 101150067149 abaA gene Proteins 0.000 claims description 9
- 239000003242 anti bacterial agent Substances 0.000 claims description 8
- 101710203837 Replication-associated protein Proteins 0.000 claims description 7
- 101100490563 Caenorhabditis elegans adr-1 gene Proteins 0.000 claims description 6
- 101150009243 HAP1 gene Proteins 0.000 claims description 6
- 230000010261 cell growth Effects 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- -1 Stre Proteins 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 4
- 238000004520 electroporation Methods 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 210000001938 protoplast Anatomy 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 229940057952 methanol Drugs 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 152
- 230000000694 effects Effects 0.000 description 99
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 89
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 82
- 235000018102 proteins Nutrition 0.000 description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 58
- 230000001105 regulatory effect Effects 0.000 description 47
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 41
- 230000006698 induction Effects 0.000 description 39
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 37
- 229910052799 carbon Inorganic materials 0.000 description 37
- 108010025188 Alcohol oxidase Proteins 0.000 description 33
- 238000004519 manufacturing process Methods 0.000 description 32
- 241000320412 Ogataea angusta Species 0.000 description 28
- 229940088598 enzyme Drugs 0.000 description 26
- 230000001965 increasing effect Effects 0.000 description 26
- 102000004190 Enzymes Human genes 0.000 description 25
- 108090000790 Enzymes Proteins 0.000 description 25
- 239000005090 green fluorescent protein Substances 0.000 description 21
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 239000013612 plasmid Substances 0.000 description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- 235000011187 glycerol Nutrition 0.000 description 15
- 101150006240 AOX2 gene Proteins 0.000 description 14
- 239000012190 activator Substances 0.000 description 14
- 238000011144 upstream manufacturing Methods 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 13
- 238000013518 transcription Methods 0.000 description 13
- 230000035897 transcription Effects 0.000 description 13
- 230000033228 biological regulation Effects 0.000 description 12
- 239000000872 buffer Substances 0.000 description 12
- 238000002703 mutagenesis Methods 0.000 description 12
- 231100000350 mutagenesis Toxicity 0.000 description 12
- 230000014616 translation Effects 0.000 description 12
- 101100268906 Mus musculus Acox1 gene Proteins 0.000 description 11
- 238000003556 assay Methods 0.000 description 11
- 230000005284 excitation Effects 0.000 description 11
- 230000001976 improved effect Effects 0.000 description 11
- 238000010367 cloning Methods 0.000 description 10
- 230000029058 respiratory gaseous exchange Effects 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 108010067193 Formaldehyde transketolase Proteins 0.000 description 9
- 241001138401 Kluyveromyces lactis Species 0.000 description 9
- 108700026226 TATA Box Proteins 0.000 description 9
- 241000222124 [Candida] boidinii Species 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 230000010354 integration Effects 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 230000037361 pathway Effects 0.000 description 9
- 210000002824 peroxisome Anatomy 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 238000002741 site-directed mutagenesis Methods 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 238000004925 denaturation Methods 0.000 description 8
- 230000036425 denaturation Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 108020004705 Codon Proteins 0.000 description 7
- 230000004913 activation Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 230000000881 depressing effect Effects 0.000 description 7
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 7
- 230000002414 glycolytic effect Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 230000000858 peroxisomal effect Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 230000000754 repressing effect Effects 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 6
- 108010034634 Repressor Proteins Proteins 0.000 description 6
- 102000009661 Repressor Proteins Human genes 0.000 description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 230000034659 glycolysis Effects 0.000 description 6
- 230000000977 initiatory effect Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 6
- 230000000241 respiratory effect Effects 0.000 description 6
- 230000002103 transcriptional effect Effects 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 6
- 101100055370 Candida boidinii AOD1 gene Proteins 0.000 description 5
- FNZLKVNUWIIPSJ-RFZPGFLSSA-N D-xylulose 5-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-RFZPGFLSSA-N 0.000 description 5
- 241000206602 Eukaryota Species 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 241001452677 Ogataea methanolica Species 0.000 description 5
- 102000001253 Protein Kinase Human genes 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 210000000172 cytosol Anatomy 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 238000007857 nested PCR Methods 0.000 description 5
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 5
- 230000004108 pentose phosphate pathway Effects 0.000 description 5
- 230000026731 phosphorylation Effects 0.000 description 5
- 238000006366 phosphorylation reaction Methods 0.000 description 5
- 108060006633 protein kinase Proteins 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 101710187573 Alcohol dehydrogenase 2 Proteins 0.000 description 4
- 101710133776 Alcohol dehydrogenase class-3 Proteins 0.000 description 4
- 101100437118 Arabidopsis thaliana AUG1 gene Proteins 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 108091006088 activator proteins Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 229960003121 arginine Drugs 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000003218 derepressive effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229940120503 dihydroxyacetone Drugs 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 230000037149 energy metabolism Effects 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000000411 inducer Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000036438 mutation frequency Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 4
- 230000035806 respiratory chain Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- SBKVPJHMSUXZTA-MEJXFZFPSA-N (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 SBKVPJHMSUXZTA-MEJXFZFPSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- 102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 101100437119 Arabidopsis thaliana AUG2 gene Proteins 0.000 description 3
- 102100035882 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 102100040428 Chitobiosyldiphosphodolichol beta-mannosyltransferase Human genes 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 108091035707 Consensus sequence Proteins 0.000 description 3
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 3
- XPYBSIWDXQFNMH-UHFFFAOYSA-N D-fructose 1,6-bisphosphate Natural products OP(=O)(O)OCC(O)C(O)C(O)C(=O)COP(O)(O)=O XPYBSIWDXQFNMH-UHFFFAOYSA-N 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 101000891557 Homo sapiens Chitobiosyldiphosphodolichol beta-mannosyltransferase Proteins 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 101100502336 Komagataella pastoris FLD1 gene Proteins 0.000 description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 108010019653 Pwo polymerase Proteins 0.000 description 3
- 101100421128 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SEI1 gene Proteins 0.000 description 3
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 3
- 108091081024 Start codon Proteins 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 3
- 241000235015 Yarrowia lipolytica Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 229940095074 cyclic amp Drugs 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000000556 factor analysis Methods 0.000 description 3
- RNBGYGVWRKECFJ-UHFFFAOYSA-N fructose-1,6-phosphate Natural products OC1C(O)C(O)(COP(O)(O)=O)OC1COP(O)(O)=O RNBGYGVWRKECFJ-UHFFFAOYSA-N 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 3
- 108010051015 glutathione-independent formaldehyde dehydrogenase Proteins 0.000 description 3
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 229960002885 histidine Drugs 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229960003136 leucine Drugs 0.000 description 3
- 230000009021 linear effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012092 media component Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 150000002482 oligosaccharides Polymers 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 238000002708 random mutagenesis Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000001718 repressive effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000005026 transcription initiation Effects 0.000 description 3
- 230000014621 translational initiation Effects 0.000 description 3
- 229940035893 uracil Drugs 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 101150061183 AOX1 gene Proteins 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101100124874 Caenorhabditis elegans hsf-1 gene Proteins 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 238000007399 DNA isolation Methods 0.000 description 2
- 101150105088 Dele1 gene Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 101150069554 HIS4 gene Proteins 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 101000913652 Mus musculus Fibronectin type III domain-containing protein 5 Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 101000621749 Penicillium citrinum Peroxiredoxin Pen c 3 Proteins 0.000 description 2
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 2
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 2
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 102100036049 T-complex protein 1 subunit gamma Human genes 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 102000014701 Transketolase Human genes 0.000 description 2
- 108010043652 Transketolase Proteins 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 108091005971 Wild-type GFP Proteins 0.000 description 2
- 101710185494 Zinc finger protein Proteins 0.000 description 2
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
- 230000008436 biogenesis Effects 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 230000004186 co-expression Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 230000004110 gluconeogenesis Effects 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- NNICRUQPODTGRU-UHFFFAOYSA-N mandelonitrile Chemical compound N#CC(O)C1=CC=CC=C1 NNICRUQPODTGRU-UHFFFAOYSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 210000001700 mitochondrial membrane Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000007981 phosphate-citrate buffer Substances 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108020003519 protein disulfide isomerase Proteins 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 230000037432 silent mutation Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 108091006106 transcriptional activators Proteins 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- WONYMNWUJVKVII-UHFFFAOYSA-N 3,5-diiodothyropropionic acid Chemical compound IC1=CC(CCC(=O)O)=CC(I)=C1OC1=CC=C(O)C=C1 WONYMNWUJVKVII-UHFFFAOYSA-N 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 101150078509 ADH2 gene Proteins 0.000 description 1
- 101150005709 ARG4 gene Proteins 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- VWEWCZSUWOEEFM-WDSKDSINSA-N Ala-Gly-Ala-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(O)=O VWEWCZSUWOEEFM-WDSKDSINSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 101100378521 Arabidopsis thaliana ADH2 gene Proteins 0.000 description 1
- 101100163849 Arabidopsis thaliana ARS1 gene Proteins 0.000 description 1
- 101000651036 Arabidopsis thaliana Galactolipid galactosyltransferase SFR2, chloroplastic Proteins 0.000 description 1
- 101100036901 Arabidopsis thaliana RPL40B gene Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 101150027801 CTA1 gene Proteins 0.000 description 1
- 101100273295 Candida albicans (strain SC5314 / ATCC MYA-2876) CAT1 gene Proteins 0.000 description 1
- 101000620266 Candida boidinii Putative peroxiredoxin-A Proteins 0.000 description 1
- 101000620273 Candida boidinii Putative peroxiredoxin-B Proteins 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 102100034330 Chromaffin granule amine transporter Human genes 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 102000003813 Cis-trans-isomerases Human genes 0.000 description 1
- 108090000175 Cis-trans-isomerases Proteins 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 102100030497 Cytochrome c Human genes 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
- KTVPXOYAKDPRHY-SOOFDHNKSA-N D-ribofuranose 5-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O KTVPXOYAKDPRHY-SOOFDHNKSA-N 0.000 description 1
- 102100037373 DNA-(apurinic or apyrimidinic site) endonuclease Human genes 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102100030012 Deoxyribonuclease-1 Human genes 0.000 description 1
- 101100440789 Dictyostelium discoideum cxfA gene Proteins 0.000 description 1
- GNGACRATGGDKBX-UHFFFAOYSA-N Dihydroxyacetone phosphate Natural products OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 1
- 108091026908 Downstream promoter element Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101150034017 FDH1 gene Proteins 0.000 description 1
- 101710088570 Flagellar hook-associated protein 1 Proteins 0.000 description 1
- 101710088566 Flagellar hook-associated protein 2 Proteins 0.000 description 1
- 108010057573 Flavoproteins Proteins 0.000 description 1
- 102000003983 Flavoproteins Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 101150094690 GAL1 gene Proteins 0.000 description 1
- 101150037782 GAL2 gene Proteins 0.000 description 1
- 101150039048 GCR1 gene Proteins 0.000 description 1
- 102100028501 Galanin peptides Human genes 0.000 description 1
- 102100021735 Galectin-2 Human genes 0.000 description 1
- 102100040004 Gamma-glutamylcyclotransferase Human genes 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 102000030595 Glucokinase Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 1
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 101000641221 Homo sapiens Chromaffin granule amine transporter Proteins 0.000 description 1
- 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
- 101000886680 Homo sapiens Gamma-glutamylcyclotransferase Proteins 0.000 description 1
- 101000957437 Homo sapiens Mitochondrial carnitine/acylcarnitine carrier protein Proteins 0.000 description 1
- 101000619805 Homo sapiens Peroxiredoxin-5, mitochondrial Proteins 0.000 description 1
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 1
- 101000595467 Homo sapiens T-complex protein 1 subunit gamma Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102100039384 Huntingtin-associated protein 1 Human genes 0.000 description 1
- 240000007454 Inga laurina Species 0.000 description 1
- 235000011752 Inga laurina Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 101710123588 Low-affinity glucose transporter Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102100038738 Mitochondrial carnitine/acylcarnitine carrier protein Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 230000004988 N-glycosylation Effects 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 108010047956 Nucleosomes Proteins 0.000 description 1
- 230000004989 O-glycosylation Effects 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 1
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 1
- 102100022078 Peroxiredoxin-5, mitochondrial Human genes 0.000 description 1
- 108010085186 Peroxisomal Targeting Signals Proteins 0.000 description 1
- 102000001105 Phosphofructokinases Human genes 0.000 description 1
- 108010069341 Phosphofructokinases Proteins 0.000 description 1
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010053763 Pyruvate Carboxylase Proteins 0.000 description 1
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- 101150055709 SNF1 gene Proteins 0.000 description 1
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 1
- 101100123443 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HAP4 gene Proteins 0.000 description 1
- 101000636911 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial Proteins 0.000 description 1
- 241000235060 Scheffersomyces stipitis Species 0.000 description 1
- 101100097319 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ala1 gene Proteins 0.000 description 1
- 101100446293 Schizosaccharomyces pombe (strain 972 / ATCC 24843) fbh1 gene Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 101150094640 Siae gene Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 101150001810 TEAD1 gene Proteins 0.000 description 1
- 101150074253 TEF1 gene Proteins 0.000 description 1
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 1
- 102100036407 Thioredoxin Human genes 0.000 description 1
- 101710195626 Transcriptional activator protein Proteins 0.000 description 1
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 1
- 101100004044 Vigna radiata var. radiata AUX22B gene Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 241000235029 Zygosaccharomyces bailii Species 0.000 description 1
- VWWQXMAJTJZDQX-DZGRYVTPSA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@H](O)[C@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-DZGRYVTPSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108020004166 alternative oxidase Proteins 0.000 description 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000009015 carbon catabolite repression of transcription Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 101150062912 cct3 gene Proteins 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 101150061265 cox6 gene Proteins 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007357 dehydrogenase reaction Methods 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 102000035175 foldases Human genes 0.000 description 1
- 108091005749 foldases Proteins 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 244000000008 fungal human pathogen Species 0.000 description 1
- 101150073818 gap gene Proteins 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000009643 growth defect Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000006122 isoprenylation Effects 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000004142 macroautophagy Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- WABYCCJHARSRBH-UHFFFAOYSA-N metaclazepam Chemical compound C12=CC(Br)=CC=C2N(C)C(COC)CN=C1C1=CC=CC=C1Cl WABYCCJHARSRBH-UHFFFAOYSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000004917 microautophagy Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- CJWXCNXHAIFFMH-AVZHFPDBSA-N n-[(2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5r)-2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl]oxy-3,5-dihydroxy-6-methyloxan-4-yl]acetamide Chemical compound C[C@H]1O[C@@H](O[C@@H]([C@@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)[C@H](O)[C@@H](NC(C)=O)[C@@H]1O CJWXCNXHAIFFMH-AVZHFPDBSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 210000001623 nucleosome Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 208000003580 polydactyly Diseases 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 230000020978 protein processing Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 230000018406 regulation of metabolic process Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 102200091760 rs1043302 Human genes 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- GUGNSJAORJLKGP-UHFFFAOYSA-K sodium 8-methoxypyrene-1,3,6-trisulfonate Chemical group [Na+].[Na+].[Na+].C1=C2C(OC)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 GUGNSJAORJLKGP-UHFFFAOYSA-K 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000008866 synergistic binding Effects 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000009614 wildtype growth Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
- C12Y101/03013—Alcohol oxidase (1.1.3.13)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (39)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0030405A AT501955B1 (de) | 2005-02-23 | 2005-02-23 | Mutierte aox1-promotoren |
| US11/817,005 US9012175B2 (en) | 2005-02-23 | 2006-02-23 | Mutant AOX1 promoters |
| KR1020077021821A KR101352399B1 (ko) | 2005-02-23 | 2006-02-23 | 돌연변이 ａｏｘ1 프로모터 |
| DK06704721.7T DK1851312T5 (da) | 2005-02-23 | 2006-02-23 | Mutant AOX 1 promotorer |
| CN2010101738787A CN101935657B (zh) | 2005-02-23 | 2006-02-23 | 突变aox1启动子 |
| PCT/AT2006/000079 WO2006089329A2 (en) | 2005-02-23 | 2006-02-23 | Mutant aox 1 promoters |
| EP10155180A EP2199389B1 (en) | 2005-02-23 | 2006-02-23 | Mutant AOX1 promoters |
| DE602006018113T DE602006018113D1 (de) | 2005-02-23 | 2006-02-23 | Mutierte aox1 promotoren |
| HK08108778.3A HK1113172B (en) | 2005-02-23 | 2006-02-23 | Mutant aox 1 promoters |
| PL10155180T PL2199389T3 (pl) | 2005-02-23 | 2006-02-23 | Zmutowane promotory AOX1 |
| AT06704721T ATE487788T1 (de) | 2005-02-23 | 2006-02-23 | Mutierte aox1 promotoren |
| PL06704721T PL1851312T3 (pl) | 2005-02-23 | 2006-02-23 | Zmutowane promotory AOX1 |
| DE602006019789T DE602006019789D1 (de) | 2005-02-23 | 2006-02-23 | Mutant AOX1 Promotoren |
| UAA201012563A UA98604C2 (ru) | 2005-02-23 | 2006-02-23 | Мутантные промоторы аох1 |
| AT10155180T ATE496125T1 (de) | 2005-02-23 | 2006-02-23 | Mutant aox1 promotoren |
| AU2006216094A AU2006216094B2 (en) | 2005-02-23 | 2006-02-23 | Mutant AOX 1 promoters |
| SI200630919T SI1851312T1 (sl) | 2005-02-23 | 2006-02-23 | Mutantni AOX 1 promotorji |
| IN6694DEN2012 IN2012DN06694A (https=) | 2005-02-23 | 2006-02-23 | |
| ES06704721T ES2356127T3 (es) | 2005-02-23 | 2006-02-23 | Promotores mutantes de aox 1. |
| NZ560542A NZ560542A (en) | 2005-02-23 | 2006-02-23 | Mutant AOX 1 promoters |
| ES10155180T ES2358086T3 (es) | 2005-02-23 | 2006-02-23 | Promotores aox1 mutantes. |
| NZ585821A NZ585821A (en) | 2005-02-23 | 2006-02-23 | Mutant AOX 1 promoters |
| KR1020127018581A KR101358663B1 (ko) | 2005-02-23 | 2006-02-23 | 돌연변이 ａｏｘ1 프로모터 |
| DK10155180.2T DK2199389T3 (da) | 2005-02-23 | 2006-02-23 | Mutant AOX1 promotere |
| BRPI0606179-6A BRPI0606179B1 (pt) | 2005-02-23 | 2006-02-23 | Promotor isolado de álcool oxidase 1 (aox1) de pichia pastoris, vetor, célula, kit, método para a expressão de uma proteína recombinante, peptídeo ou ácido nucléico funcional, em uma célula, método para a expressão de uma molécula de ácido nucleico para a expressão de uma proteína, peptídeo ou ácido nucléico funcional, e método para o isolamento de clones de superexpressão |
| CA2785161A CA2785161C (en) | 2005-02-23 | 2006-02-23 | Mutant aox1 promoters |
| UAA200710436A UA94399C2 (ru) | 2005-02-23 | 2006-02-23 | Мутантные промоторы аох1 |
| PT06704721T PT1851312E (pt) | 2005-02-23 | 2006-02-23 | Promotores de aox1 mutantes |
| SI200630962T SI2199389T1 (sl) | 2005-02-23 | 2006-02-23 | Mutantni AOX1 promotorji |
| CA2598514A CA2598514C (en) | 2005-02-23 | 2006-02-23 | Mutant aox 1 promoters |
| EP06704721A EP1851312B9 (en) | 2005-02-23 | 2006-02-23 | Mutant aox 1 promoters |
| JP2007556461A JP5497986B2 (ja) | 2005-02-23 | 2006-02-23 | 突然変異体ａｏｘ１プロモーター |
| CN2006800058881A CN101128581B (zh) | 2005-02-23 | 2006-02-23 | 突变aox1启动子 |
| HR20110084T HRP20110084T2 (hr) | 2005-02-23 | 2006-02-23 | Promotori mutantne aox1 |
| HK11102457.9A HK1148313B (en) | 2005-02-23 | 2008-08-08 | Mutant aox 1 promoters |
| US12/759,763 US9279129B2 (en) | 2005-02-23 | 2010-04-14 | Mutant AOX1 promoters |
| AU2011200187A AU2011200187B2 (en) | 2005-02-23 | 2011-01-18 | Mutant AOX 1 Promoters |
| HR20110254T HRP20110254T1 (hr) | 2005-02-23 | 2011-04-08 | Promotori mutantne aox1 |
| JP2011245688A JP5552107B2 (ja) | 2005-02-23 | 2011-11-09 | 突然変異体ａｏｘ１プロモーター |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0030405A AT501955B1 (de) | 2005-02-23 | 2005-02-23 | Mutierte aox1-promotoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AT501955A1 AT501955A1 (de) | 2006-12-15 |
| AT501955B1 true AT501955B1 (de) | 2007-08-15 |
Family
ID=36927772
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0030405A AT501955B1 (de) | 2005-02-23 | 2005-02-23 | Mutierte aox1-promotoren |
| AT10155180T ATE496125T1 (de) | 2005-02-23 | 2006-02-23 | Mutant aox1 promotoren |
| AT06704721T ATE487788T1 (de) | 2005-02-23 | 2006-02-23 | Mutierte aox1 promotoren |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT10155180T ATE496125T1 (de) | 2005-02-23 | 2006-02-23 | Mutant aox1 promotoren |
| AT06704721T ATE487788T1 (de) | 2005-02-23 | 2006-02-23 | Mutierte aox1 promotoren |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9012175B2 (https=) |
| EP (2) | EP2199389B1 (https=) |
| JP (2) | JP5497986B2 (https=) |
| KR (2) | KR101352399B1 (https=) |
| CN (2) | CN101128581B (https=) |
| AT (3) | AT501955B1 (https=) |
| AU (2) | AU2006216094B2 (https=) |
| BR (1) | BRPI0606179B1 (https=) |
| CA (2) | CA2598514C (https=) |
| DE (2) | DE602006018113D1 (https=) |
| DK (2) | DK1851312T5 (https=) |
| ES (2) | ES2356127T3 (https=) |
| HR (2) | HRP20110084T2 (https=) |
| IN (1) | IN2012DN06694A (https=) |
| NZ (2) | NZ585821A (https=) |
| PL (2) | PL2199389T3 (https=) |
| PT (1) | PT1851312E (https=) |
| SI (2) | SI1851312T1 (https=) |
| UA (2) | UA98604C2 (https=) |
| WO (1) | WO2006089329A2 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0906241B8 (pt) * | 2008-03-27 | 2019-02-19 | Alliance Sustainable Energy | molécula de ácido nucleico, gene quimérico, vetor e método de transformação de uma célula bacteriana |
| WO2010004042A2 (en) * | 2008-07-11 | 2010-01-14 | Novozymes A/S | Pichia pastoris das promoter variants |
| EP2258855A1 (en) | 2009-05-28 | 2010-12-08 | Universität für Bodenkultur Wien | Expression sequences |
| US20140011236A1 (en) * | 2011-03-22 | 2014-01-09 | Merch Sharp & Dohme Corp. | Promoters for high level recombinant expression in fungal host cells |
| GB201113419D0 (en) * | 2011-08-04 | 2011-09-21 | Fujifilm Diosynth Biotechnologies Uk Ltd | Yeast vector |
| EP2565262A1 (en) | 2011-08-31 | 2013-03-06 | VTU Holding GmbH | Protein expression |
| TWI560272B (en) | 2011-10-07 | 2016-12-01 | Lonza Ag | Regulatable promoter |
| WO2014088563A1 (en) * | 2012-12-05 | 2014-06-12 | Exxonmobil Research And Engineering Company | Nannochloropsis kozak consensus sequence |
| DK3527667T3 (da) | 2013-03-08 | 2021-02-22 | Biogrammatics Inc | Gærpromotorer til proteinekspression |
| ES2738181T3 (es) | 2013-03-08 | 2020-01-20 | Keck Graduate Inst Of Applied Life Sciences | Promotores de levadura de Pichia pastoris |
| US9150870B2 (en) | 2013-03-15 | 2015-10-06 | Lonza Ltd. | Constitutive promoter |
| JP6698352B2 (ja) | 2013-03-15 | 2020-05-27 | ロンザ リミテッドＬｏｎｚａ Ｌｉｍｉｔｅｄ | 構成的プロモーター |
| JP2018501814A (ja) | 2014-11-11 | 2018-01-25 | クララ フーズ カンパニー | 卵白タンパク質産生のための方法および組成物 |
| EP3294762B1 (en) | 2015-05-11 | 2022-01-19 | Impossible Foods Inc. | Expression constructs and methods of genetically engineering methylotrophic yeast |
| DK3332005T3 (da) | 2015-08-05 | 2022-01-03 | Lonza Ag | Promotorvarianter |
| CN108728477B (zh) * | 2017-04-24 | 2022-02-22 | 华东理工大学 | 一种高效的转座突变系统及构建方法 |
| KR102596200B1 (ko) * | 2017-06-30 | 2023-10-30 | 다우 글로벌 테크놀로지스 엘엘씨 | 알데히드 개선을 위한 코팅 및 이의 제조 방법 |
| EP3802832A1 (en) | 2018-06-07 | 2021-04-14 | Basf Se | Promoter for yeast |
| EP3824083A4 (en) * | 2018-09-24 | 2022-01-05 | Orta Dogu Teknik Universitesi | Design of alcohol dehydrogenase 2 (adh2) promoter variants by promoter engineering |
| JP2022502018A (ja) * | 2018-09-24 | 2022-01-11 | オルタ ドグ テクニク ユニヴェルシテシ | 改変されたａｏｘ１プロモータバリアント |
| CN110029122B (zh) * | 2019-03-19 | 2022-03-01 | 青岛蔚蓝生物集团有限公司 | 一种甘露聚糖酶高产菌株及其应用 |
| CN109735547B (zh) * | 2019-03-19 | 2022-05-31 | 青岛蔚蓝生物集团有限公司 | 一种提高毕赤酵母外源蛋白表达量的启动子及其应用 |
| CN110029120B (zh) * | 2019-03-19 | 2022-03-01 | 青岛蔚蓝生物集团有限公司 | 一种植酸酶高产菌株及其应用 |
| KR20210153106A (ko) * | 2019-04-17 | 2021-12-16 | 임파서블 푸즈 인크. | 단백질 생산을 위한 물질 및 방법 |
| CN110106168B (zh) * | 2019-05-27 | 2021-07-13 | 西南大学 | 基于转录因子间的互作关系构建双激素响应启动子的方法 |
| US12096784B2 (en) | 2019-07-11 | 2024-09-24 | Clara Foods Co. | Protein compositions and consumable products thereof |
| BR112022000545A2 (pt) | 2019-07-11 | 2022-04-05 | Clara Foods Co | Composições de proteína e produtos de consumo destas |
| US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
| CN110724720A (zh) * | 2019-11-01 | 2020-01-24 | 山东仙普爱瑞科技股份有限公司 | 一种猪α-干扰素的发酵工艺 |
| EP3922726A1 (en) * | 2020-06-10 | 2021-12-15 | Erber Aktiengesellschaft | Truncated promoter for recombinant gene expression |
| IL304910A (en) | 2021-02-12 | 2023-10-01 | Boehringer Ingelheim Rcv Gmbh | Signal peptides for increased protein secretion |
| CA3131181C (en) * | 2021-06-24 | 2023-03-07 | BioBoost Synbio Consulting Inc. | Method for methanol free culturing of methylotrophic yeast for the biosynthesis of added value products |
| EP4726051A1 (en) | 2023-06-06 | 2026-04-15 | FUJIFILM Corporation | Recombinant yeast, method for producing target protein, and kit and method for producing recombinant yeast |
| CN121358867A (zh) * | 2023-06-15 | 2026-01-16 | 丹斯塔发酵股份公司 | C2碳源响应性启动子 |
| CN117417934B (zh) * | 2023-10-27 | 2024-09-13 | 江南大学 | 跨菌种启动子、多菌种穿梭质粒及其应用 |
| WO2025104126A1 (en) | 2023-11-14 | 2025-05-22 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Tags for enhanced expression of recombinant proteins |
| WO2025163019A1 (en) | 2024-02-01 | 2025-08-07 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Tags for enhanced expression of recombinant proteins |
| WO2026027251A1 (en) | 2024-08-01 | 2026-02-05 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Signal peptides for increased protein secretion |
| CN118599913B (zh) * | 2024-08-07 | 2024-12-27 | 南昌大学 | 醛氧化酶Aox1基因敲除动物模型的构建方法及应用 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610036A (en) * | 1991-03-27 | 1997-03-11 | The Green Cross Corporation | Mutant AOX2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism |
| US5641661A (en) * | 1993-03-25 | 1997-06-24 | Biosource Technologies, Inc. | Pichia pastoris alcohol oxidase ZZA1 and ZZA2 regulatory regions for heterologous gene expression |
| US5643792A (en) * | 1993-01-13 | 1997-07-01 | The Green Cross Corporation | Mutant strain of Pichia pastoris which utilizes methanol in the presence of glucose |
| EP0510693B1 (en) * | 1991-04-25 | 1999-03-03 | Research Corporation Technologies, Inc. | Expression of human serum albumin in pichia pastoris |
| EP0931837A1 (en) * | 1998-01-27 | 1999-07-28 | Mitsui Chemicals, Inc. | Method for producing phytase |
| EP0967275A1 (en) * | 1997-08-29 | 1999-12-29 | Kirin Beer Kabushiki Kaisha | Dna sequences enhancing promoter activity |
| WO2000056903A2 (en) * | 1999-03-22 | 2000-09-28 | Zymogenetics, Inc. | IMPROVED METHODS FOR PRODUCING PROTEINS IN TRANSFORMED $i(PICHIA) |
| US6699691B2 (en) * | 2001-04-05 | 2004-03-02 | The Board Of Regents Of The University Of Nebraska | Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| EP1431387A1 (en) * | 2002-12-20 | 2004-06-23 | Roche Diagnostics GmbH | Heat-labile desoxyribonculease I variants |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1188524C (zh) * | 2001-02-28 | 2005-02-09 | 珠江医院 | 人SP－A1在pichia pastoris中的表达 |
-
2005
- 2005-02-23 AT AT0030405A patent/AT501955B1/de not_active IP Right Cessation
-
2006
- 2006-02-23 ES ES06704721T patent/ES2356127T3/es not_active Expired - Lifetime
- 2006-02-23 HR HR20110084T patent/HRP20110084T2/hr unknown
- 2006-02-23 DK DK06704721.7T patent/DK1851312T5/da active
- 2006-02-23 AT AT10155180T patent/ATE496125T1/de active
- 2006-02-23 NZ NZ585821A patent/NZ585821A/en not_active IP Right Cessation
- 2006-02-23 EP EP10155180A patent/EP2199389B1/en not_active Expired - Lifetime
- 2006-02-23 CA CA2598514A patent/CA2598514C/en not_active Expired - Lifetime
- 2006-02-23 AT AT06704721T patent/ATE487788T1/de active
- 2006-02-23 DE DE602006018113T patent/DE602006018113D1/de not_active Expired - Lifetime
- 2006-02-23 KR KR1020077021821A patent/KR101352399B1/ko not_active Expired - Lifetime
- 2006-02-23 SI SI200630919T patent/SI1851312T1/sl unknown
- 2006-02-23 EP EP06704721A patent/EP1851312B9/en not_active Expired - Lifetime
- 2006-02-23 WO PCT/AT2006/000079 patent/WO2006089329A2/en not_active Ceased
- 2006-02-23 KR KR1020127018581A patent/KR101358663B1/ko not_active Expired - Lifetime
- 2006-02-23 UA UAA201012563A patent/UA98604C2/ru unknown
- 2006-02-23 NZ NZ560542A patent/NZ560542A/en not_active IP Right Cessation
- 2006-02-23 DE DE602006019789T patent/DE602006019789D1/de not_active Expired - Lifetime
- 2006-02-23 PT PT06704721T patent/PT1851312E/pt unknown
- 2006-02-23 US US11/817,005 patent/US9012175B2/en active Active
- 2006-02-23 CN CN2006800058881A patent/CN101128581B/zh not_active Expired - Lifetime
- 2006-02-23 UA UAA200710436A patent/UA94399C2/ru unknown
- 2006-02-23 PL PL10155180T patent/PL2199389T3/pl unknown
- 2006-02-23 CN CN2010101738787A patent/CN101935657B/zh not_active Expired - Lifetime
- 2006-02-23 JP JP2007556461A patent/JP5497986B2/ja not_active Expired - Lifetime
- 2006-02-23 AU AU2006216094A patent/AU2006216094B2/en not_active Expired
- 2006-02-23 CA CA2785161A patent/CA2785161C/en not_active Expired - Lifetime
- 2006-02-23 SI SI200630962T patent/SI2199389T1/sl unknown
- 2006-02-23 BR BRPI0606179-6A patent/BRPI0606179B1/pt active IP Right Grant
- 2006-02-23 IN IN6694DEN2012 patent/IN2012DN06694A/en unknown
- 2006-02-23 ES ES10155180T patent/ES2358086T3/es not_active Expired - Lifetime
- 2006-02-23 PL PL06704721T patent/PL1851312T3/pl unknown
- 2006-02-23 DK DK10155180.2T patent/DK2199389T3/da active
-
2010
- 2010-04-14 US US12/759,763 patent/US9279129B2/en active Active
-
2011
- 2011-01-18 AU AU2011200187A patent/AU2011200187B2/en not_active Expired
- 2011-04-08 HR HR20110254T patent/HRP20110254T1/hr unknown
- 2011-11-09 JP JP2011245688A patent/JP5552107B2/ja not_active Expired - Lifetime
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610036A (en) * | 1991-03-27 | 1997-03-11 | The Green Cross Corporation | Mutant AOX2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism |
| EP0506040B1 (en) * | 1991-03-27 | 1998-07-01 | The Green Cross Corporation | Mutant AOX2 promotor, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism |
| EP0510693B1 (en) * | 1991-04-25 | 1999-03-03 | Research Corporation Technologies, Inc. | Expression of human serum albumin in pichia pastoris |
| US5643792A (en) * | 1993-01-13 | 1997-07-01 | The Green Cross Corporation | Mutant strain of Pichia pastoris which utilizes methanol in the presence of glucose |
| US5641661A (en) * | 1993-03-25 | 1997-06-24 | Biosource Technologies, Inc. | Pichia pastoris alcohol oxidase ZZA1 and ZZA2 regulatory regions for heterologous gene expression |
| EP0967275A1 (en) * | 1997-08-29 | 1999-12-29 | Kirin Beer Kabushiki Kaisha | Dna sequences enhancing promoter activity |
| EP0931837A1 (en) * | 1998-01-27 | 1999-07-28 | Mitsui Chemicals, Inc. | Method for producing phytase |
| WO2000056903A2 (en) * | 1999-03-22 | 2000-09-28 | Zymogenetics, Inc. | IMPROVED METHODS FOR PRODUCING PROTEINS IN TRANSFORMED $i(PICHIA) |
| US6699691B2 (en) * | 2001-04-05 | 2004-03-02 | The Board Of Regents Of The University Of Nebraska | Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| EP1431387A1 (en) * | 2002-12-20 | 2004-06-23 | Roche Diagnostics GmbH | Heat-labile desoxyribonculease I variants |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT501955B1 (de) | Mutierte aox1-promotoren | |
| KR102253479B1 (ko) | 프로모터 변이체 | |
| DE69805627T2 (de) | Verbesserte stämme für die protein-expression | |
| US11214809B2 (en) | Vector containing centromere DNA sequence and use thereof | |
| JP5997140B2 (ja) | 生産細胞株 | |
| DE102011056290A1 (de) | Pilzstämme mit genetischer modifikation betreffend einen carbonsäure-transporter | |
| HK1113172B (en) | Mutant aox 1 promoters | |
| HK1148313B (en) | Mutant aox 1 promoters | |
| DE10022334A1 (de) | Proteinproduktion in der Hefe Arxula | |
| AT515155A1 (de) | Mutante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EIH | Change in the person of patent owner | ||
| MM01 | Lapse because of not paying annual fees |
Effective date: 20120223 |